There was no difference in PFS between the two arms for the overall cohort ( median 1.9 vs 2.1 months ) ; an improved median PFS was observed in the combination arm ( N = 11 ) over single agent ( N = 10 ) in the prespecified leiomyosarcoma stratum ( median 3.7 vs 1.8 months ; P = 0.01 ) .